Stock price when the opinion was issued
Still growing topline and bottom line at double digits. Spewing lots of free cash, buying back stock, great balance sheet. Worry is about how will AI affect its business? No evidence yet that it's impacting any of the company's results. Market's not respecting the fundamentals at the moment, maybe rightly so.
He bought more. They beat top and bottom lines, and raised guidance. He's a value investor. Sure, the share price has been terrible, but their earnings estimates are starting to rise and they're buying back share to reduce the share count 5% in the past year. They are meeting the competitive threat through their beats and guidance. They outperform consistently. Eventually, the share price will rise.
Still stands out, but the fear is that it won't in the world of AI. And that's why it looks particularly interesting. Good earnings, upped guidance, yet stock fell. Valuation has collapsed to 17x PE. Still likely to grow double-digit EPS this year, and consensus is still 14-15% EPS growth over the next 3 years.
There is more competition, but it's spending 18% of sales on R&D, so something compelling will turn up. No dividend.
Their December results beat, but they lowered 2025 guidance by 1.5%. Shares fell 20%, an overreaction. Investors are worried about Adobe's pace of AI progress, but things should improve this year as they create more optimal pricing, including affordable rates for poorer customers. Their express product will compete with Canva. Meanwhile, they're targeting the enterprise market with GenStudio, an AI factory for advertisers. Note: the CEO of Eli Lilly recently bought $1 million of Adobe shares, as he sits on the board.
(Analysts’ price target is $576.85)